<?xml version="1.0" encoding="UTF-8"?>
<ref id="B24-pharmaceutics-13-00230">
 <label>24.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Badolato</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Carullo</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Perri</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Cione</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Manetti</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Di Gioia</surname>
    <given-names>M.L.</given-names>
   </name>
   <name>
    <surname>Brizzi</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Caroleo</surname>
    <given-names>M.C.</given-names>
   </name>
   <name>
    <surname>Aiello</surname>
    <given-names>F.</given-names>
   </name>
  </person-group>
  <article-title>Quercetin/oleic acid-based G-protein-coupled receptor 40 ligands as new insulin secretion modulators</article-title>
  <source>Future Med. Chem.</source>
  <year>2017</year>
  <volume>9</volume>
  <fpage>1873</fpage>
  <lpage>1885</lpage>
  <pub-id pub-id-type="doi">10.4155/fmc-2017-0113</pub-id>
  <pub-id pub-id-type="pmid">29064290</pub-id>
 </element-citation>
</ref>
